1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Esclerosis Múltiple

Esclerosis Múltiple

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Alcina A, Fedetz M, Vidal-Cobo I, Andrés-León E, García-Sánchez MI, Barroso-Del-Jesus A, Eichau S, Gil-Varea E, Villar LM, Saiz A, Leyva L, Vandenbroeck K, Otaegui D, Izquierdo G, Comabella M, Urcelay E, Matesanz F.

    Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis

    HUMAN MOLECULAR GENETICS . 31(13): 2155-2163. Nº de citas: 4

    [doi:10.1093/hmg/ddac009]

  • Brieva L, Estruch BC, Merino JAG, Meca-Lallana V, Río J, Rodríguez-Antigüedad A, Agüera E, Ara JR, Luque AA, Garcia CA, Blanco Y, Castillo-Triviño T, Costa-Frossard L, González Platas M, Pascual LL, Llaneza-González M, Ginés MLM, Matías-Guiu J, Meca-Lallana JE, Bilbao MM, Sempere AP, Romero-Pinel L, Saiz A, Moral E.

    Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology

    MULTIPLE SCLEROSIS AND RELATED DISORDERS . 63: 103805-103805. Nº de citas: 1

    [doi:10.1016/j.msard.2022.103805]

  • Lopez-Soley E, Meca-Lallana JE, Llufriu S, Blanco Y, Gómez-Ballesteros R, Maurino J, Pérez-Miralles F, Forero L, Calles C, Martinez-Gines ML, Gonzalez-Suarez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Sepulveda M, Solana E.

    Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder

    Journal of Personalized Medicine . 12(5): . Nº de citas: 4

    [doi:10.3390/jpm12050743]

  • Matute-Blanch C, Brito V, Midaglia L, Villar LM, Garcia-Diaz Barriga G, Guzman de la Fuente A, Borrás E, Fernández-García S, Calvo-Barreiro L, Miguez A, Costa-Frossard L, Pinteac R, Sabidó E, Alberch J, Fitzgerald DC, Montalban X, Comabella M.

    Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non-cell-autonomous neuronal damage

    Clinical And Translational Medicine . 12(5): . Nº de citas: 3

    [doi:10.1002/ctm2.837]

  • Sáez-Landete I, Gómez-Domínguez A, Estrella-León B, Díaz-Cid A, Fedirchyk O, Escribano-Muñoz M, Pedrera-Mazarro A, Martín-Palomeque G, Garcia-Ribas G, Rodríguez-Jorge F, Santos-Pérez G, Lourido-García D, Regidor-BaillyBailliere I.

    Retrospective Analysis of EEG in Patients With COVID-19: EEG Recording in Acute and Follow-up Phases.

    CLINICAL EEG AND NEUROSCIENCE . 53(3): 215-228. Nº de citas: 5

    [doi:10.1177/15500594211035923]

  • Fernández-Velasco JI, Monreal E, Kuhle J, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Oreja-Guevara C, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Lapuente-Suanzes P, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Diaz-Pérez C, Valero-López G, Diaz-Diaz J, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, García-Domínguez JM, Sabin J, Llufriu S, Masjuan J, Costa-Frossard L, Villar LM.

    Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.

    Frontiers in immunology . 13: 842354-842354.

    [doi:10.3389/fimmu.2022.842354]

  • Sainz de la Maza S, Sabin Muñoz J, Pilo de la Fuente B, Thuissard I, Andreu-Vázquez C, Galán Sánchez-Seco V, Salgado-Cámara P, Costa-Frossard L, Monreal E, Ayuso-Peralta L, García-Vasco L, García-Domínguez JM, Martínez-Ginés ML, Muñoz Fernández C, Díaz-Díaz J, Oreja-Guevara C, Gómez-Moreno M, Martín H, Rubio-Flores L, Blasco MR, Villar-Guimerans LM, Aladro Y.

    Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis

    MULTIPLE SCLEROSIS AND RELATED DISORDERS . 59: 103669-103669. Nº de citas: 3

    [doi:10.1016/j.msard.2022.103669]

  • Sainz de la Maza S, Maurino J, Borges M, Martín-Martínez J, Sotoca J, Alonso A, Caminero AB, Borrega L, Sánchez-Menoyo JL, Barrero-Hernández FJ, Calles C, Brieva L, Blasco MR, García-Soto JD, Campo-Amigo MD, Navarro-Cantó L, Agüera E, Garcés M, Carmona O, Gabaldón-Torres L, Forero L, Hervás M, de Alda LR, Gómez-Ballesteros R, Castillo-Triviño T.

    Measuring productivity loss in early relapsing-remitting multiple sclerosis

    MULTIPLE SCLEROSIS AND RELATED DISORDERS . 58: 103398-103398. Nº de citas: 4

    [doi:10.1016/j.msard.2021.103398]

  • Mena J, Alloza I, Tulloch Navarro R, Aldekoa A, Díez García J, Villanueva Etxebarria A, Lindskog C, Antigüedad A, Boyero S, Mendibe-Bilbao MDM, Álvarez de Arcaya A, Sánchez Menoyo JL, Midaglia L, Villarrubia N, Malhotra S, Montalban X, Villar LM, Comabella M, Vandenbroeck K.

    Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55-IL6ST Gene Region in Immature Dendritic Cells

    Frontiers in immunology . 12: 816930-816930. Nº de citas: 6

    [doi:10.3389/fimmu.2021.816930]

  • Pestaña D, Villar L, Gomez-Rojo M, Roy G, Olmedillo B, Giménez C, Zambrana P, Guisado G, Aláez A, Bardi T.

    Respiratory mechanics in late COVID-19 ARDS - a restrictive pattern is strongly associated with death. A cohort study.

    Anaesthesiology Intensive Therapy . 54(4): 295-301.

    [doi:10.5114/ait.2022.121091]

  • Coll-Martinez C, Quintana E, Salavedra-Pont J, Buxó M, González-Del-Rio M, Gómez I, Muñoz-San Martín M, Villar LM, Álvarez-Bravo G, Robles-Cedeño R, Ramió-Torrentà L, Gich J.

    Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

    BRAIN AND BEHAVIOR . 11(12): .

    [doi:10.1002/brb3.2405]

  • Pérez-Pérez S, Domínguez-Mozo MI, García-Martínez MÁ, García-Frontini MC, Villarrubia N, Costa-Frossard L, Villar LM, Arroyo R, Álvarez-Lafuente R.

    Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression.

    Frontiers in immunology . 12: 798003-798003. Nº de citas: 2

    [doi:10.3389/fimmu.2021.798003]

  • Comabella M, Sastre-Garriga J, Borras E, Villar LM, Saiz A, Martínez-Yélamos S, García-Merino JA, Pinteac R, Fissolo N, Sánchez López AJ, Costa-Frossard L, Blanco Y, Llufriu S, Vidal-Jordana A, Sabidó E, Montalban X.

    CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis.

    Neurology(R) neuroimmunology & neuroinflammation . 8(6): . Nº de citas: 9

    [doi:10.1212/NXI.0000000000001082]

  • Moreno-Torres I, Meca Lallana V, Costa-Frossard L, Oreja-Guevara C, Aguirre C, Alba Suárez EM, Gómez Moreno M, Borrega Canelo L, Muñoz JS, Aladro Y, Cárcamo Fonfría A, Rodríguez García E, Cuello JP, Monreal E, Sainz de la Maza S, Pérez Parra F, Valenzuela Rojas F, López de Silanes de Miguel C, Casanova I, Martínez M, Blasco R, Orviz García A, Villar-Guimerans LM, Fernández-Dono G, Elvira V, Santiuste C, Espiño M, García Domínguez JM.

    Risk and outcomes of covid-19 in patients with multiple sclerosis.

    EUROPEAN JOURNAL OF NEUROLOGY . 28(11): 3712-3721. Nº de citas: 19

    [doi:10.1111/ene.14990]

  • Walo-Delgado PE, Monreal E, Medina S, Quintana E, Sainz de la Maza S, Fernández-Velasco JI, Lapuente P, Comabella M, Ramió-Torrentà L, Montalban X, Midaglia L, Villarrubia N, Carrasco-Sayalero A, Rodríguez-Martín E, Roldán E, Meca-Lallana J, Alvarez-Lafuente R, Masjuan J, Costa-Frossard L, Villar LM.

    Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab

    Frontiers in immunology . 12: 760546-760546. Nº de citas: 1

    [doi:10.3389/fimmu.2021.760546]

  • Fernandez O, Costa-Frossard L.

    Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat(®) Methodology.

    Frontiers in Neurology . 12: 722801-722801. Nº de citas: 5

    [doi:10.3389/fneur.2021.722801]

  • Mestre L, Alonso G, Feliú A, Mecha M, Martín C, Villar LM, Guaza C.

    Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis

    Aging Cell . 20(9): . Nº de citas: 1

    [doi:10.1111/acel.13440]

  • Monreal E, Sainz de la Maza S, Costa-Frossard L, Walo-Delgado P, Zamora J, Fernández-Velasco JI, Villarrubia N, Espiño M, Lourido D, Lapuente P, Toboso I, Álvarez-Cermeño JC, Masjuan J, Villar LM.

    Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome

    Neurology(R) neuroimmunology & neuroinflammation . 8(5): . Nº de citas: 12

    [doi:10.1212/NXI.0000000000001047]